Cleared Traditional

K251881 - HippoMind (v1.0) (FDA 510(k) Clearance)

Dec 2025
Decision
168d
Days
Class 2
Risk

K251881 is an FDA 510(k) clearance for the HippoMind (v1.0). This device is classified as a Non-normalizing Quantitative Electroencephalograph Software (Class II - Special Controls, product code OLT).

Submitted by Hippoclinic (Mountain View, US). The FDA issued a Cleared decision on December 3, 2025, 168 days after receiving the submission on June 18, 2025.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Analyze Electroencephalograph Data Using Conventional Methodology To Output And Display Standard Electroencephalograph Parameters For Interpretation By A Qualified User..

Submission Details

510(k) Number K251881 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 2025
Decision Date December 03, 2025
Days to Decision 168 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OLT - Non-normalizing Quantitative Electroencephalograph Software
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Analyze Electroencephalograph Data Using Conventional Methodology To Output And Display Standard Electroencephalograph Parameters For Interpretation By A Qualified User.